JP2014521620A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521620A5 JP2014521620A5 JP2014522035A JP2014522035A JP2014521620A5 JP 2014521620 A5 JP2014521620 A5 JP 2014521620A5 JP 2014522035 A JP2014522035 A JP 2014522035A JP 2014522035 A JP2014522035 A JP 2014522035A JP 2014521620 A5 JP2014521620 A5 JP 2014521620A5
- Authority
- JP
- Japan
- Prior art keywords
- oxo
- indazole
- carboxamide
- dihydro
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 23
- 125000003118 aryl group Chemical group 0.000 claims 20
- 125000000623 heterocyclic group Chemical group 0.000 claims 20
- 125000001072 heteroaryl group Chemical group 0.000 claims 16
- 125000000753 cycloalkyl group Chemical group 0.000 claims 15
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002431 hydrogen Chemical class 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 8
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 7
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- -1 substituents Halogen Chemical class 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 229910052740 iodine Inorganic materials 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- YGWYOZIKVSOHMN-UHFFFAOYSA-N 1-ethyl-3-oxo-2-piperidin-4-ylindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(CC)N1C1CCNCC1 YGWYOZIKVSOHMN-UHFFFAOYSA-N 0.000 claims 1
- QBPZRWOAIYPXFL-UHFFFAOYSA-N 1-ethyl-6-fluoro-3-oxo-2-piperidin-4-ylindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(CC)N1C1CCNCC1 QBPZRWOAIYPXFL-UHFFFAOYSA-N 0.000 claims 1
- VJFVDUPSYQILQW-UHFFFAOYSA-N 1-methyl-2-(1-methylpiperidin-4-yl)-3-oxoindazole-4-carboxamide Chemical compound C1CN(C)CCC1N1C(=O)C2=C(C(N)=O)C=CC=C2N1C VJFVDUPSYQILQW-UHFFFAOYSA-N 0.000 claims 1
- MGGYINOUFRKASP-UHFFFAOYSA-N 1-methyl-3-oxo-2-(1-phenylpiperidin-4-yl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1C1=CC=CC=C1 MGGYINOUFRKASP-UHFFFAOYSA-N 0.000 claims 1
- QTAAMFZROWGTBV-UHFFFAOYSA-N 1-methyl-3-oxo-2-(1-propan-2-ylpiperidin-4-yl)indazole-4-carboxamide Chemical compound C1CN(C(C)C)CCC1N1C(=O)C2=C(C(N)=O)C=CC=C2N1C QTAAMFZROWGTBV-UHFFFAOYSA-N 0.000 claims 1
- DQUPPBNAKKNJCG-UHFFFAOYSA-N 1-methyl-3-oxo-2-(1-pyridin-3-ylpiperidin-4-yl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1C1=CC=CN=C1 DQUPPBNAKKNJCG-UHFFFAOYSA-N 0.000 claims 1
- ISZXVGQBWFOMRH-UHFFFAOYSA-N 1-methyl-3-oxo-2-(1-pyridin-4-ylpiperidin-4-yl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1C1=CC=NC=C1 ISZXVGQBWFOMRH-UHFFFAOYSA-N 0.000 claims 1
- OKQHBZNTIODWFQ-UHFFFAOYSA-N 1-methyl-3-oxo-2-(4-piperidin-4-ylphenyl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(C=C1)=CC=C1C1CCNCC1 OKQHBZNTIODWFQ-UHFFFAOYSA-N 0.000 claims 1
- CRRYCTZISQQIEO-UHFFFAOYSA-N 1-methyl-3-oxo-2-(4-pyridin-4-ylphenyl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(C=C1)=CC=C1C1=CC=NC=C1 CRRYCTZISQQIEO-UHFFFAOYSA-N 0.000 claims 1
- AFJWZGCQRIBDPC-UHFFFAOYSA-N 1-methyl-3-oxo-2-[1-(1h-pyrrol-2-ylmethyl)piperidin-4-yl]indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1CC1=CC=CN1 AFJWZGCQRIBDPC-UHFFFAOYSA-N 0.000 claims 1
- YPXYVWLWTAQXOJ-UHFFFAOYSA-N 1-methyl-3-oxo-2-[1-(1h-pyrrol-3-ylmethyl)piperidin-4-yl]indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1CC=1C=CNC=1 YPXYVWLWTAQXOJ-UHFFFAOYSA-N 0.000 claims 1
- TVMQVMPQEYUIGQ-UHFFFAOYSA-N 1-methyl-3-oxo-2-[1-(thiophen-2-ylmethyl)piperidin-4-yl]indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1CC1=CC=CS1 TVMQVMPQEYUIGQ-UHFFFAOYSA-N 0.000 claims 1
- XCMZWTDSYWVLET-UHFFFAOYSA-N 1-methyl-3-oxo-2-piperidin-4-ylindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C1CCNCC1 XCMZWTDSYWVLET-UHFFFAOYSA-N 0.000 claims 1
- UUQRRSAKFTVLLN-UHFFFAOYSA-N 2-(1-benzylpiperidin-4-yl)-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1CC1=CC=CC=C1 UUQRRSAKFTVLLN-UHFFFAOYSA-N 0.000 claims 1
- KLJGXEJQJQJADT-UHFFFAOYSA-N 2-(1-benzylpiperidin-4-yl)-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1CC1=CC=CC=C1 KLJGXEJQJQJADT-UHFFFAOYSA-N 0.000 claims 1
- QNLAVJXTBVYHBB-UHFFFAOYSA-N 2-(1-cyclobutylpiperidin-4-yl)-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1C1CCC1 QNLAVJXTBVYHBB-UHFFFAOYSA-N 0.000 claims 1
- VPFGQWNBEHLGLL-UHFFFAOYSA-N 2-(1-cyclobutylpiperidin-4-yl)-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1C1CCC1 VPFGQWNBEHLGLL-UHFFFAOYSA-N 0.000 claims 1
- WTZNVEJNRDYVFN-UHFFFAOYSA-N 2-(1-cyclobutylpiperidin-4-yl)-6-fluoro-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(CC1)CCN1C1CCC1 WTZNVEJNRDYVFN-UHFFFAOYSA-N 0.000 claims 1
- DHHMUTDEQQNNOC-UHFFFAOYSA-N 2-(1-cyclobutylpiperidin-4-yl)-6-fluoro-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC(F)=CC=2NN1C(CC1)CCN1C1CCC1 DHHMUTDEQQNNOC-UHFFFAOYSA-N 0.000 claims 1
- LQCUWVHLGPGETP-UHFFFAOYSA-N 2-(1-cyclohexylazetidin-3-yl)-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(C1)CN1C1CCCCC1 LQCUWVHLGPGETP-UHFFFAOYSA-N 0.000 claims 1
- UXDSIJGLPLQLFE-UHFFFAOYSA-N 2-(1-cyclohexylazetidin-3-yl)-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(C1)CN1C1CCCCC1 UXDSIJGLPLQLFE-UHFFFAOYSA-N 0.000 claims 1
- FGIOTWXUGHYOKV-UHFFFAOYSA-N 2-(1-cyclohexylazetidin-3-yl)-6-fluoro-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(C1)CN1C1CCCCC1 FGIOTWXUGHYOKV-UHFFFAOYSA-N 0.000 claims 1
- FEKOIQNXQNTNKL-UHFFFAOYSA-N 2-(1-cyclohexylpiperidin-4-yl)-1-ethyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(CC)N1C(CC1)CCN1C1CCCCC1 FEKOIQNXQNTNKL-UHFFFAOYSA-N 0.000 claims 1
- XPKUFZAKPWQMOR-UHFFFAOYSA-N 2-(1-cyclohexylpiperidin-4-yl)-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1C1CCCCC1 XPKUFZAKPWQMOR-UHFFFAOYSA-N 0.000 claims 1
- XEWGITPSXRGTBO-UHFFFAOYSA-N 2-(1-cyclohexylpiperidin-4-yl)-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1C1CCCCC1 XEWGITPSXRGTBO-UHFFFAOYSA-N 0.000 claims 1
- PQXUCBRUEQVEIZ-UHFFFAOYSA-N 2-(1-cyclohexylpiperidin-4-yl)-6-fluoro-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(CC1)CCN1C1CCCCC1 PQXUCBRUEQVEIZ-UHFFFAOYSA-N 0.000 claims 1
- OKBDXGNRRUXLQE-UHFFFAOYSA-N 2-(1-cyclohexylpiperidin-4-yl)-6-fluoro-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC(F)=CC=2NN1C(CC1)CCN1C1CCCCC1 OKBDXGNRRUXLQE-UHFFFAOYSA-N 0.000 claims 1
- NPMKKPKCZJHHCM-UHFFFAOYSA-N 2-(1-cyclopentylpiperidin-4-yl)-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1C1CCCC1 NPMKKPKCZJHHCM-UHFFFAOYSA-N 0.000 claims 1
- OVJIYLSTZRNOLG-UHFFFAOYSA-N 2-(1-cyclopentylpiperidin-4-yl)-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1C1CCCC1 OVJIYLSTZRNOLG-UHFFFAOYSA-N 0.000 claims 1
- SAMGXLVBURJEJM-UHFFFAOYSA-N 2-(1-ethylpiperidin-4-yl)-1-methyl-3-oxoindazole-4-carboxamide Chemical compound C1CN(CC)CCC1N1C(=O)C2=C(C(N)=O)C=CC=C2N1C SAMGXLVBURJEJM-UHFFFAOYSA-N 0.000 claims 1
- ZQZRXPFBEJPPKJ-UHFFFAOYSA-N 2-(1-ethylpiperidin-4-yl)-3-oxo-1h-indazole-4-carboxamide Chemical compound C1CN(CC)CCC1N1C(=O)C2=C(C(N)=O)C=CC=C2N1 ZQZRXPFBEJPPKJ-UHFFFAOYSA-N 0.000 claims 1
- SBXCLTZHGFAEGE-UHFFFAOYSA-N 2-(1-methylpiperidin-4-yl)-3-oxo-1h-indazole-4-carboxamide Chemical compound C1CN(C)CCC1N1C(=O)C2=C(C(N)=O)C=CC=C2N1 SBXCLTZHGFAEGE-UHFFFAOYSA-N 0.000 claims 1
- NWULWFVQKLIALI-UHFFFAOYSA-N 2-[1-(4,4-dichlorocyclohexyl)piperidin-4-yl]-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1C1CCC(Cl)(Cl)CC1 NWULWFVQKLIALI-UHFFFAOYSA-N 0.000 claims 1
- IMXAAXJRLKLQGB-UHFFFAOYSA-N 2-[1-(4,4-difluorocyclohexyl)piperidin-4-yl]-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1C1CCC(F)(F)CC1 IMXAAXJRLKLQGB-UHFFFAOYSA-N 0.000 claims 1
- WEUSDVLSZAFNCO-UHFFFAOYSA-N 2-[1-(4,4-difluorocyclohexyl)piperidin-4-yl]-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1C1CCC(F)(F)CC1 WEUSDVLSZAFNCO-UHFFFAOYSA-N 0.000 claims 1
- DNUXFVBNRHFGHK-UHFFFAOYSA-N 2-[1-(4,4-difluorocyclohexyl)piperidin-4-yl]-6-fluoro-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(CC1)CCN1C1CCC(F)(F)CC1 DNUXFVBNRHFGHK-UHFFFAOYSA-N 0.000 claims 1
- SBDYFIHZQFQZCK-UHFFFAOYSA-N 2-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1CC1CCC=CC1 SBDYFIHZQFQZCK-UHFFFAOYSA-N 0.000 claims 1
- MHOBIUHIHRMJRE-UHFFFAOYSA-N 2-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1CC1CCC=CC1 MHOBIUHIHRMJRE-UHFFFAOYSA-N 0.000 claims 1
- HHODORPGMSMXQA-UHFFFAOYSA-N 2-[1-(cyclohexylmethyl)piperidin-4-yl]-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1CC1CCCCC1 HHODORPGMSMXQA-UHFFFAOYSA-N 0.000 claims 1
- HTUDQMHOVIPNPF-UHFFFAOYSA-N 2-[1-(cyclohexylmethyl)piperidin-4-yl]-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1CC1CCCCC1 HTUDQMHOVIPNPF-UHFFFAOYSA-N 0.000 claims 1
- FRGMDGKFVLOUCT-UHFFFAOYSA-N 2-[1-(furan-2-ylmethyl)piperidin-4-yl]-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1CC1=CC=CO1 FRGMDGKFVLOUCT-UHFFFAOYSA-N 0.000 claims 1
- VFQDKRSLDGWGBS-UHFFFAOYSA-N 2-[1-(furan-3-ylmethyl)piperidin-4-yl]-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=CC=C2N(C)N1C(CC1)CCN1CC=1C=COC=1 VFQDKRSLDGWGBS-UHFFFAOYSA-N 0.000 claims 1
- QKJLENNBYDTENH-UHFFFAOYSA-N 2-[1-(furan-3-ylmethyl)piperidin-4-yl]-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1CC=1C=COC=1 QKJLENNBYDTENH-UHFFFAOYSA-N 0.000 claims 1
- JHOLYZMPGXNVHM-UHFFFAOYSA-N 3-oxo-2-(1-phenylpiperidin-4-yl)-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1C1=CC=CC=C1 JHOLYZMPGXNVHM-UHFFFAOYSA-N 0.000 claims 1
- XTQOVBDMXJLDKF-UHFFFAOYSA-N 3-oxo-2-(1-propan-2-ylpiperidin-4-yl)-1h-indazole-4-carboxamide Chemical compound C1CN(C(C)C)CCC1N1C(=O)C2=C(C(N)=O)C=CC=C2N1 XTQOVBDMXJLDKF-UHFFFAOYSA-N 0.000 claims 1
- OSXUFLZXPJVGDL-UHFFFAOYSA-N 3-oxo-2-(1-propylpiperidin-4-yl)-1h-indazole-4-carboxamide Chemical compound C1CN(CCC)CCC1N1C(=O)C2=C(C(N)=O)C=CC=C2N1 OSXUFLZXPJVGDL-UHFFFAOYSA-N 0.000 claims 1
- WIZBDMUANSAVNW-UHFFFAOYSA-N 3-oxo-2-(1-pyridin-3-ylpiperidin-4-yl)-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1C1=CC=CN=C1 WIZBDMUANSAVNW-UHFFFAOYSA-N 0.000 claims 1
- ZPNWGLVAEKFEGJ-UHFFFAOYSA-N 3-oxo-2-(1-pyridin-4-ylpiperidin-4-yl)-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1C1=CC=NC=C1 ZPNWGLVAEKFEGJ-UHFFFAOYSA-N 0.000 claims 1
- RXSSHKKBZKSMAA-UHFFFAOYSA-N 3-oxo-2-(4-piperidin-4-ylphenyl)-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(C=C1)=CC=C1C1CCNCC1 RXSSHKKBZKSMAA-UHFFFAOYSA-N 0.000 claims 1
- IXTUKDJLYHRMHS-UHFFFAOYSA-N 3-oxo-2-(4-pyridin-3-ylphenyl)-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(C=C1)=CC=C1C1=CC=CN=C1 IXTUKDJLYHRMHS-UHFFFAOYSA-N 0.000 claims 1
- BIDBVMUJMSZKGL-UHFFFAOYSA-N 3-oxo-2-(4-pyridin-4-ylphenyl)-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(C=C1)=CC=C1C1=CC=NC=C1 BIDBVMUJMSZKGL-UHFFFAOYSA-N 0.000 claims 1
- KZGFROWNSPDFSG-UHFFFAOYSA-N 3-oxo-2-[1-(1h-pyrrol-3-ylmethyl)piperidin-4-yl]-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1CC=1C=CNC=1 KZGFROWNSPDFSG-UHFFFAOYSA-N 0.000 claims 1
- OLJDWQJXPVXMDC-UHFFFAOYSA-N 3-oxo-2-[1-(thiophen-2-ylmethyl)piperidin-4-yl]-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1CC1=CC=CS1 OLJDWQJXPVXMDC-UHFFFAOYSA-N 0.000 claims 1
- IIMXWNUUYOPBPC-UHFFFAOYSA-N 3-oxo-2-[1-(thiophen-3-ylmethyl)piperidin-4-yl]-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C(CC1)CCN1CC=1C=CSC=1 IIMXWNUUYOPBPC-UHFFFAOYSA-N 0.000 claims 1
- OQWUKVQDDJFORM-UHFFFAOYSA-N 3-oxo-2-piperidin-4-yl-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC=CC=2NN1C1CCNCC1 OQWUKVQDDJFORM-UHFFFAOYSA-N 0.000 claims 1
- OYACMDIHHCFBEK-UHFFFAOYSA-N 6-chloro-2-(1-cyclohexylpiperidin-4-yl)-1-methyl-3-oxoindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(Cl)C=C2N(C)N1C(CC1)CCN1C1CCCCC1 OYACMDIHHCFBEK-UHFFFAOYSA-N 0.000 claims 1
- VHKWRLIBQRSCLB-UHFFFAOYSA-N 6-chloro-2-(1-cyclohexylpiperidin-4-yl)-3-oxo-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC(Cl)=CC=2NN1C(CC1)CCN1C1CCCCC1 VHKWRLIBQRSCLB-UHFFFAOYSA-N 0.000 claims 1
- VNNYGCPDAUKGHU-UHFFFAOYSA-N 6-fluoro-1-methyl-3-oxo-2-(1-pyridin-3-ylpiperidin-4-yl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(CC1)CCN1C1=CC=CN=C1 VNNYGCPDAUKGHU-UHFFFAOYSA-N 0.000 claims 1
- ZSHKOFQSHKXRRJ-UHFFFAOYSA-N 6-fluoro-1-methyl-3-oxo-2-(1-pyridin-4-ylpiperidin-4-yl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(CC1)CCN1C1=CC=NC=C1 ZSHKOFQSHKXRRJ-UHFFFAOYSA-N 0.000 claims 1
- NRYJYZXKRNBMDC-UHFFFAOYSA-N 6-fluoro-1-methyl-3-oxo-2-(4-piperidin-4-ylphenyl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(C=C1)=CC=C1C1CCNCC1 NRYJYZXKRNBMDC-UHFFFAOYSA-N 0.000 claims 1
- KUFKAXXFHXOUQP-UHFFFAOYSA-N 6-fluoro-1-methyl-3-oxo-2-(4-pyridin-3-ylphenyl)indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(C=C1)=CC=C1C1=CC=CN=C1 KUFKAXXFHXOUQP-UHFFFAOYSA-N 0.000 claims 1
- LFUACUPDCBGSDC-UHFFFAOYSA-N 6-fluoro-1-methyl-3-oxo-2-[1-(thiophen-3-ylmethyl)piperidin-4-yl]indazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C(CC1)CCN1CC=1C=CSC=1 LFUACUPDCBGSDC-UHFFFAOYSA-N 0.000 claims 1
- LIGDLZRFUNWVFK-UHFFFAOYSA-N 6-fluoro-1-methyl-3-oxo-2-piperidin-4-ylindazole-4-carboxamide Chemical compound O=C1C2=C(C(N)=O)C=C(F)C=C2N(C)N1C1CCNCC1 LIGDLZRFUNWVFK-UHFFFAOYSA-N 0.000 claims 1
- RIBLUSFTXIMKAZ-UHFFFAOYSA-N 6-fluoro-3-oxo-2-(4-pyridin-3-ylphenyl)-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC(F)=CC=2NN1C(C=C1)=CC=C1C1=CC=CN=C1 RIBLUSFTXIMKAZ-UHFFFAOYSA-N 0.000 claims 1
- QSOQCQWTGJEJJX-UHFFFAOYSA-N 6-fluoro-3-oxo-2-piperidin-4-yl-1h-indazole-4-carboxamide Chemical compound O=C1C=2C(C(=O)N)=CC(F)=CC=2NN1C1CCNCC1 QSOQCQWTGJEJJX-UHFFFAOYSA-N 0.000 claims 1
- 102000015087 Poly (ADP-Ribose) Polymerase-1 Human genes 0.000 claims 1
- 108010064218 Poly (ADP-Ribose) Polymerase-1 Proteins 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 238000011319 anticancer therapy Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000002140 halogenating effect Effects 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11175355.4 | 2011-07-26 | ||
| EP11175355 | 2011-07-26 | ||
| EP12167336.2 | 2012-05-09 | ||
| EP12167336 | 2012-05-09 | ||
| PCT/EP2012/064054 WO2013014038A1 (en) | 2011-07-26 | 2012-07-18 | 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014521620A JP2014521620A (ja) | 2014-08-28 |
| JP2014521620A5 true JP2014521620A5 (enExample) | 2015-08-20 |
| JP5902299B2 JP5902299B2 (ja) | 2016-04-13 |
Family
ID=46545382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014522035A Active JP5902299B2 (ja) | 2011-07-26 | 2012-07-18 | Ｐａｒｐ−１阻害剤としての３−オキソ−２，３−ジヒドロ−１ｈ−インダゾール−４−カルボキサミド誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9073893B2 (enExample) |
| EP (1) | EP2736896B1 (enExample) |
| JP (1) | JP5902299B2 (enExample) |
| ES (1) | ES2616464T3 (enExample) |
| WO (1) | WO2013014038A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104230896A (zh) * | 2013-06-17 | 2014-12-24 | 上海汇伦生命科技有限公司 | 苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途 |
| UY36628A (es) | 2015-04-17 | 2016-11-30 | Abbvie Inc | Indazolonas como moduladores de la señalización de tnf |
| EP3288939A1 (en) | 2015-04-17 | 2018-03-07 | AbbVie Inc. | Tricyclic modulators of tnf signaling |
| UY36629A (es) | 2015-04-17 | 2016-11-30 | Abbvie Inc | Indazolonas como moduladores de la señalización de tnf |
| IL317573A (en) | 2022-06-15 | 2025-02-01 | Astrazeneca Ab | Combination therapy for cancer treatment |
| WO2024231548A1 (en) | 2023-05-11 | 2024-11-14 | Astrazeneca Ab | Combination of a parp1 inhibitor and a selective estrogen degrader for treating cancer |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5036083A (en) | 1988-07-15 | 1991-07-30 | Ici Pharma | Heterocyclic agents |
| IL143303A0 (en) * | 1998-11-27 | 2002-04-21 | Basf Ag | Substituted benzimidazoles and their use as parp inhibitors |
| DE19918211A1 (de) * | 1999-04-22 | 2000-10-26 | Basf Ag | Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung |
| AU7314200A (en) * | 1999-09-17 | 2001-04-24 | Yamanouchi Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
| JPWO2002100833A1 (ja) | 2001-06-12 | 2004-09-24 | 住友製薬株式会社 | Ｒｈｏキナーゼ阻害剤 |
| DE602004023062D1 (en) * | 2003-03-31 | 2009-10-22 | Lilly Co Eli | 3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitoren |
| CN101316834A (zh) * | 2005-09-29 | 2008-12-03 | 艾博特公司 | 在2位取代有苯基的1h-苯并咪唑-4-甲酰胺是强效parp抑制剂 |
| US7462724B2 (en) * | 2005-11-15 | 2008-12-09 | Abbott Laboratories | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors |
| AU2007232297B2 (en) * | 2006-04-03 | 2012-09-20 | Msd Italia S.R.L. | Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors |
| EP3536690A1 (en) * | 2007-01-10 | 2019-09-11 | MSD Italia S.r.l. | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| WO2008141385A1 (en) * | 2007-05-21 | 2008-11-27 | Biota Scientific Management Pty Ltd | Viral polymerase inhibitors |
| US8067613B2 (en) * | 2007-07-16 | 2011-11-29 | Abbott Laboratories | Benzimidazole poly(ADP ribose)polymerase inhibitors |
| TWI499418B (zh) | 2009-05-21 | 2015-09-11 | Nerviano Medical Sciences Srl | 異喹啉－１（２ｈ）－酮衍生物 |
| US8765972B2 (en) * | 2009-07-14 | 2014-07-01 | Nerviano Medical Sciences S.R.L. | 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides with selective PARP-1 inhibition |
| ES2759751T3 (es) * | 2009-07-14 | 2020-05-12 | Nerviano Medical Sciences Srl | 3-oxo-2,3-dihidro-1H-isoindol-4-carboxamidas |
-
2012
- 2012-07-18 WO PCT/EP2012/064054 patent/WO2013014038A1/en not_active Ceased
- 2012-07-18 ES ES12737279.5T patent/ES2616464T3/es active Active
- 2012-07-18 EP EP12737279.5A patent/EP2736896B1/en active Active
- 2012-07-18 US US14/233,963 patent/US9073893B2/en active Active
- 2012-07-18 JP JP2014522035A patent/JP5902299B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521620A5 (enExample) | ||
| ES2574253T3 (es) | Nuevo agente antiplaquetario | |
| JP2011510929A5 (enExample) | ||
| JP2020523388A5 (enExample) | ||
| JP2018527295A5 (enExample) | ||
| JP2013528204A5 (enExample) | ||
| JP2013507425A5 (enExample) | ||
| JP2012525431A5 (enExample) | ||
| JP2016516043A5 (enExample) | ||
| JP2018515555A5 (enExample) | ||
| KR20150118148A (ko) | Trk 저해 화합물 | |
| JP2017530187A5 (enExample) | ||
| JP2013505969A5 (enExample) | ||
| JP2010523576A5 (enExample) | ||
| CA2734415A1 (en) | Picolinamide derivatives as kinase inhibitors | |
| JP2016525076A5 (enExample) | ||
| RU2013126094A (ru) | Замещённые пиразолопиримидины как активаторы глюкоцереброзидазы | |
| JP2020512343A5 (enExample) | ||
| JP2017525668A5 (enExample) | ||
| JP2012528166A5 (enExample) | ||
| JP2013542261A5 (enExample) | ||
| JP2016525075A5 (enExample) | ||
| JP2010539110A5 (enExample) | ||
| JP2009523777A5 (enExample) | ||
| JP2011517697A5 (enExample) |